Bayer eyes launch of heart, menopause relief drugs in 2025 Ruchika Sharma8 April 2025 12:30 PM ISTLondon: Bayer said it is gearing up to launch two new pharmaceutical products this year, each with the potential to generate more than $1 billion in...
Breakthrough in Menopause Treatment: Elinzanetant Cuts Hot Flashes and Enhances Sleep, New Trials Reveal Medha Baranwal26 Aug 2024 6:15 AM ISTUSA: Recent findings from the OASIS 1 and OASIS 2 randomized clinical trials highlight the potential of Elinzanetant as a significant advancement in...
Bayer submits New Drug Application to USFDA for Elinzanetant for treatment of moderate to severe vasomotor symptoms associated with menopause Ruchika Sharma1 Aug 2024 10:00 AM ISTBerlin: Bayer has announced that a New Drug Application (NDA) for the investigational compound elinzanetant has been submitted to the U.S. Food...
Bayer to shift drug research focus away from women's health Ruchika Sharma26 March 2023 12:00 PM ISTBayer, which acquired a large women's health business under the 2006 takeover of Schering Pharma, will focus drugs research on oncology,...
